Ovarian carcinomas with choriocarcinomatous differentiation

Cancer. 1993 Oct 15;72(8):2441-6. doi: 10.1002/1097-0142(19931015)72:8<2441::aid-cncr2820720823>3.0.co;2-n.

Abstract

Background: Ovarian carcinomas may produce human chorionic gonadotropin (HCG) or HCG-like substances and may even contain syncytiotrophoblast cells, but a true choriocarcinomatous component has not been described in these tumors.

Methods: Two cases of poorly differentiated ovarian carcinoma with choriocarcinomatous components are reported. Pathologic findings were correlated with immunohistochemical stains, hormonal effects, and clinical behavior.

Results: Each tumor contained a circumscribed, extensively necrotic and hemorrhagic brown nodule. Microscopically, the nodules exhibited a mixture of cytotrophoblast and syncytiotrophoblast. The syncytiotrophoblast capped cytotrophoblast and was strongly positive for beta-HCG. In one of the cases, a transformation zone composed of poorly differentiated carcinoma with occasional beta-HCG-positive cells was observed between a mucinous cystadenoma and the choriocarcinomatous elements. The two cases exhibited activation of the ovarian stroma in the form of condensation and luteinization. Extra-abdominal metastases developed early in both patients and, despite multiagent chemotherapy, they died shortly postoperatively.

Conclusions: Choriocarcinoma may rarely develop as a result of dedifferentiation of common epithelial ovarian tumors. Recognition of choriocarcinomatous components in ovarian carcinomas is important because of its association with aggressive behavior.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carcinoma / metabolism
  • Carcinoma / pathology*
  • Choriocarcinoma / metabolism
  • Choriocarcinoma / pathology*
  • Chorionic Gonadotropin / metabolism
  • Cystadenoma, Mucinous / metabolism
  • Cystadenoma, Mucinous / pathology
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology*
  • Prognosis
  • Trophoblasts / pathology

Substances

  • Chorionic Gonadotropin